Renaissance Technologies
NUVB icon

Renaissance Technologies’s Nuvation Bio NUVB Stock Holding History

Renaissance Technologies’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.65M Buy
1,345,995
+786,815
+141% +$3.85M 0.01% 1203
2026
Q1 		$2.4M Buy
+559,180
New +$3.12M ﹤0.01% 1808
2025
Q3 		– Sell
-22,100
Closed -$43.1K – 3776
2025
Q2 		$43.1K Sell
22,100
-422,000
-95% -$879K ﹤0.01% 3413
2025
Q1 		$782K Sell
444,100
-122,700
-22% -$279K ﹤0.01% 2549
2024
Q4 		$1.51M Sell
566,800
-462,200
-45% -$1.19M ﹤0.01% 2233
2024
Q3 		$2.36M Buy
1,029,000
+268,000
+35% +$817K ﹤0.01% 1910
2024
Q2 		$2.22M Sell
761,000
-213,700
-22% -$652K ﹤0.01% 1822
2024
Q1 		$3.55M Sell
974,700
-508,431
-34% -$976K 0.01% 1640
2023
Q4 		$2.24M Buy
1,483,131
+1,093,131
+280% +$1.41M ﹤0.01% 1879
2023
Q3 		$523K Buy
390,000
+78,100
+25% +$130K ﹤0.01% 2691
2023
Q2 		$561K Buy
311,900
+38,800
+14% +$66K ﹤0.01% 2812
2023
Q1 		$453K Buy
273,100
+128,900
+89% +$261K ﹤0.01% 2935
2022
Q4 		$277K Sell
144,200
-116,315
-45% -$235K ﹤0.01% 3261
2022
Q3 		$584K Buy
260,515
+174,215
+202% +$497K ﹤0.01% 2837
2022
Q2 		$280K Sell
86,300
-5,900
-6% -$25.7K ﹤0.01% 3494
2022
Q1 		$485K Buy
92,200
+42,600
+86% +$239K ﹤0.01% 3217
2021
Q4 		$422K Sell
49,600
-800
-2% -$7.35K ﹤0.01% 3159
2021
Q3 		$501K Sell
50,400
-416,400
-89% -$3.77M ﹤0.01% 2892
2021
Q2 		$4.35M Buy
+466,800
New +$5.32M 0.01% 1716

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Renaissance Technologies's NUVB Position: Q2 2026 in Review

Renaissance Technologies increased its Nuvation Bio (NUVB) stake by 141% in Q2 2026, buying an estimated $3.85M and bringing the position to 1,345,995 shares worth $7.65M. The position accounts for 0.01% of the portfolio, ranked #1203.

Renaissance Technologies first reported a position in NUVB in Q2 2021 and has held it in 19 quarters since. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Renaissance Technologies held 1,345,995 shares of Nuvation Bio worth $7.65M as of Q2 2026.
  • Renaissance Technologies bought 786,815 Nuvation Bio shares in Q2 2026, an estimated $3.85M.
  • Nuvation Bio made up 0.01% of Renaissance Technologies's portfolio in Q2 2026, its #1203 holding.
  • Renaissance Technologies first reported a position in Nuvation Bio in Q2 2021 and has held it in 19 quarters since.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.